PBS
Panadol Osteo could double in price: Quilty
Panadol Osteo could double in price due to regulatory changes, claims the Guild’s head. Speaking on national radio, David Quilty did not hold back on his feelings and explained his concerns, especially …
Be ready for 2016 changes: Quilty
As 2016 looms, community pharmacies need to be prepared for the optional $1 script copayment discount, and the delisting of several medicines from the PBS, Guild executive director David Quilty …
Investing in new medicines pays for itself: report
A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modeling, published in The impact of pharmaceutical innovation on premature …
Pharmacists need to prepare consumers on PBS delisting: Demarte
Consumers will need to be prepared for the changes flowing from the PBS delisting of 17 types of medicines on 1 January 2016, says the PSA. The medicines include products …
17 OTC medicines removed from PBS subsidy
Minister for Health Sussan Ley today confirmed the 17 types of common OTC medicines, including paracetamol and aspirin, that will no longer be subsidised as a prescription drug under the …
Joint Position Paper signed to help ‘Close the Gap’
A Joint Position Paper calling for improvements in the Closing The Gap (CTG) PBS Co-payment measure was signed between the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Pharmacy Guild …
Health groups plead with Ley on hepatitis C cures
Twenty-seven leading medical associations and health advocacy groups have published an open letter to the Federal Health Minister urging the immediate inclusion of breakthrough hepatitis C cures on the PBS. …
Ley slams pharma companies on delaying tactics
Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a …
PWC outlines medicines industry challenges: Medicines Australia
The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …
Regulatory headaches stifling access to medicines: PwC report
TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released …
Policy keeping PBS spending in check: Medicines Australia
The release of the Final Budget Outcomes for 2014‑15 has revealed policy reforms are continuing to put downward pressure on PBS expenditure, says Medicines Australia. The final Budget papers released …
Hepatitis C patients growing sicker waiting for PBS subsidy
Nearly 3000 Australians with hepatitis C have progressed to severe liver disease in the last year, as thousands continue to wait for affordable access to curative medicines recommended for a …
